Low incidence of SARS-CoV-2 infections in healthcare workers at a tertiary care hospital : Results of a prospective serological cohort study of the first and second COVID‑19 pandemic wave

Healthcare workers caring for coronavirus disease 2019 (COVID‑19) patients are at an increased risk for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this seroepidemiological study was to evaluate the risk of infection for employees at a tertiary care hospital....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medizinische Klinik, Intensivmedizin und Notfallmedizin Intensivmedizin und Notfallmedizin, 2022-11, Vol.117 (8), p.639-643
Hauptverfasser: Hupf, Julian, Burkhardt, Ralph, Gessner, André, Maier-Stocker, Constantin, Zimmermann, Markus, Hanses, Frank, Peterhoff, David
Format: Artikel
Sprache:ger
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Healthcare workers caring for coronavirus disease 2019 (COVID‑19) patients are at an increased risk for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this seroepidemiological study was to evaluate the risk of infection for employees at a tertiary care hospital. Serological tests for antibodies against SARS-CoV‑2 were carried out in a prospective cohort of employees directly involved in the care of COVID‑19 patients every 2 weeks from March to July 2020 (1st wave). Antibody status was examined again between December 2020 and February 2021 (2nd wave). The seroprevalence of antibodies against SARS-CoV‑2 was 5.1% at the end of the study in February 2021. The cumulative incidence was 3.9% after a median observation period of 261 days. We observed a low risk of SARS-CoV‑2 infection comparable to that of the general population in the examined cohort of healthcare workers involved in the acute care of COVID‑19 patients under the applied hygiene and protective measures.
ISSN:2193-6226
DOI:10.1007/s00063-021-00890-5